Documented Clinical Outcomes
Proving Equivalency to TURP with Fewer Complications
GreenLight™ Laser Therapy offers clinical outcomes equivalent to Transurethral Resection of the Prostate (TURP) for the treatment of BPH, with fewer complications. More than 500 clinical papers and abstracts have proven the safety and efficacy of GreenLight: no significant risk of TUR syndrome, fluid absorption or blood transfusion, and no increase in erectile dysfunction postoperatively.15
AUA Symptom Score Improvement
Observations up to one year demonstrate that symptom score improvements are similar between transurethral resection of the prostate (TURP)12, GreenLight PV13, and GreenLight HPS.6
Five-year observations suggest that GreenLight PV provides significant and sustainable long-term improvements.13
|
 |
Clinical Success Equivalent
GreenLight Laser Therapy offers clinical outcomes that are similar to transurethral resection of the prostate (TURP) when used to treat BPH.6,7
- Dramatic improvement in mean peak urine flow within 24 hours with 170% to 252% improvement sustained at 3 years
|
 |
100% Catheter-Free by 23 Hours6
Many patients do not require a catheter following the procedure. If one is required, it is typically removed in less than 24 hours.
|
 |
Shorter Hospital Stay
GreenLight Laser Therapy can be performed as an outpatient procedure for healthy patients, thus lowering the expected cost per case.
- Outpatient procedure for healthy patients.
- Average patient stay for patients treated with GreenLight HPS/XPS (120 watts) was 0.9 days compared with 3.4 days for patients undergoing TURP.
|
|
Less Costly Than TURP8
GreenLight ranged from 1.3 to 3.3 times less costly than TURP in a series of comparative studies (including disposables, capital equipment, and hospitalization). |
 |
Uncomplicated Recovery
GreenLight Laser Therapy demonstrated fewer severe complications than transurethral resection of the prostate (TURP).6,7
- Postprocedural catheterization eliminated for many patients.
- For those patients requiring catheterization, mean catheterization time is 14.1 hours.
- No significant risk of TUR syndrome, fluid absorption, or blood transfusion and no increase in erectile dysfunction postoperatively.
- Low rate of sexual side effects.
- Less than 1% reported cases of erectile dysfunction.
- 36% rate of retrograde ejaculation at 1 year.
|
 |
All surgical treatments have inherent and associated risks. The most common risks associated with Photoselective Vaporization of the Prostate (PVP) are hematuria, short term dysuria and UTI. See the GreenLight Operator's Manual or Surgical Guide CD for a complete list of possible risks and complications.
See the Instructions for Use and the Operator's Manual for the complete directions, contraindications, warnings, and risks associated with the device.
For more information, visit: http://www.amselabeling.com/